Chris Conrad
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neurological disorders and treatments
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 6
- Calcium signaling and nucleotide metabolism 1
-
- Ubiquitin and proteasome pathways 2
- Mitochondrial Function and Pathology 1
- Co-authors
- Eliezer Masliah (4 shared papers)Leon J. Thal (3 shared papers)Yu Xia (3 shared papers)Peter Davies (2 shared papers)Athena Andreadis (2 shared papers)Tsunao Saitoh (2 shared papers)Robert Katzman (1 shared paper)W. C. Wiederholt (1 shared paper)
- Journals
- Journal of Neurochemistry (2 papers)Biochemical and Biophysical Research Communications (1 paper)Blood (1 paper)Autophagy (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Chris Conrad
9 papers receiving 795 citations
Peers
Comparison fields: 5 of 65
- Neurology 336
- Neurology 183
- Physiology 437
- Cellular and Molecular Neuroscience 155
- Physiology 32
Countries citing papers authored by Chris Conrad
This map shows the geographic impact of Chris Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Conrad more than expected).
Fields of papers citing papers by Chris Conrad
This network shows the impact of papers produced by Chris Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Conrad. The network helps show where Chris Conrad may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 338 | |
| 2 | 2017 | 143 | |
| 3 | 2002 | 103 | |
| 4 | 2007 | 60 | |
| 5 | 2001 | 45 | |
| 6 | 1998 | 42 | |
| 7 | 2004 | 36 | |
| 8 | 1998 | 35 | |
| 9 | 2017 | 14 |
About Chris Conrad
Chris Conrad is a scholar working on Physiology, Molecular Biology, Neurology, Cellular and Molecular Neuroscience and Pharmacology, having authored 9 papers that have together received 816 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Ubiquitin and proteasome pathways (2 papers), Estrogen and related hormone effects (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Mitochondrial Function and Pathology (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Neurology (336 citations), Neurology (183 citations), Physiology (437 citations), Cellular and Molecular Neuroscience (155 citations) and Physiology (32 citations). Chris Conrad has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Eliezer Masliah, Leon J. Thal, Yu Xia, Peter Davies, Athena Andreadis, Tsunao Saitoh, Robert Katzman, W. C. Wiederholt, Melissa Freeman and Dennis W. Dickson. Their work appears in journals such as Journal of Neurochemistry, Biochemical and Biophysical Research Communications, Blood, Autophagy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.